138 related articles for article (PubMed ID: 1976270)
1. Pattern of acid reflux in patients with reflux esophagitis 'resistant' to H2-receptor antagonists.
Bianchi Porro G; Pace F; Sangaletti O
Scand J Gastroenterol; 1990 Aug; 25(8):810-4. PubMed ID: 1976270
[TBL] [Abstract][Full Text] [Related]
2. Gastric and esophageal acidity during continuous treatment with H2-antagonists in uncomplicated esophagitis.
Fiorucci S; Santucci L; Perrone E; Abbritti F; Morelli A
Scand J Gastroenterol; 1989 Aug; 24(6):671-7. PubMed ID: 2573143
[TBL] [Abstract][Full Text] [Related]
3. [Reflux esophagitis: therapy with H2-blockers, and motility disorders].
Pace F; Sangaletti O; Zhu H; Bianchi Porro G
Minerva Chir; 1991 Apr; 46(7 Suppl):163-7. PubMed ID: 2067675
[TBL] [Abstract][Full Text] [Related]
4. Famotidine in gastroesophageal reflux disease (GERD).
Wesdorp IC
Hepatogastroenterology; 1992 Feb; 39 Suppl 1():24-6. PubMed ID: 1577391
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage].
Vasil'ev IuV; Li IA
Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271
[TBL] [Abstract][Full Text] [Related]
6. Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
Fiorucci S; Santucci L; Morelli A
Am J Gastroenterol; 1990 Nov; 85(11):1458-62. PubMed ID: 2239873
[TBL] [Abstract][Full Text] [Related]
7. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
[TBL] [Abstract][Full Text] [Related]
8. Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis.
Hatlebakk JG; Berstad A
Scand J Gastroenterol; 1996 Oct; 31(10):954-8. PubMed ID: 8898414
[TBL] [Abstract][Full Text] [Related]
9. Factors predicting relapse during maintenance treatment with famotidine in patients with healed reflux esophagitis. Dutch Esophagitis Study Group.
Wesdorp IC; Dekker W; Festen HP
Clin Ther; 1997; 19(5):1048-57. PubMed ID: 9385492
[TBL] [Abstract][Full Text] [Related]
10. Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine.
Bianchi Porro G; Pace F; Peracchia A; Bonavina L; Vigneri S; Scialabba A; Franceschi M
J Clin Gastroenterol; 1992 Oct; 15(3):192-8. PubMed ID: 1479161
[TBL] [Abstract][Full Text] [Related]
11. Failure of initial 24-hour esophageal pH monitoring to predict refractoriness and intractability in reflux esophagitis.
Olden K; Triadafilopoulos G
Am J Gastroenterol; 1991 Sep; 86(9):1142-6. PubMed ID: 1679286
[TBL] [Abstract][Full Text] [Related]
12. [Effect of oxmetidine and ranitidine on reflux behavior in patients with esophagitis].
Weiser HF; Gubernatis G; Siewert JR
Z Gastroenterol; 1983 Oct; 21(10):580-4. PubMed ID: 6139923
[TBL] [Abstract][Full Text] [Related]
13. Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Sontag SJ; Kogut DG; Fleischmann R; Campbell DR; Richter J; Robinson M; McFarland M; Sabesin S; Lehman GA; Castell D
Am J Gastroenterol; 1997 Mar; 92(3):429-37. PubMed ID: 9068463
[TBL] [Abstract][Full Text] [Related]
14. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
Pfefferkorn MD; Croffie JM; Gupta SK; Molleston JP; Eckert GJ; Corkins MR; Fitzgerald JF
J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):160-5. PubMed ID: 16456408
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of nizatidine and famotidine for maintenance therapy of erosive esophagitis.
Hamamoto N; Hashimoto T; Adachi K; Hirakawa K; Ishihara S; Inoue H; Taniura H; Niigaki M; Sato S; Kushiyama Y; Suetsugu H; Miyake T; Kinoshita Y
J Gastroenterol Hepatol; 2005 Feb; 20(2):281-6. PubMed ID: 15683433
[TBL] [Abstract][Full Text] [Related]
16. Gastro-oesophageal reflux disease in The Netherlands. Results of a multicentre pH study.
Smout AJ; Geus WP; Mulder PG; Stockbrügger RW; Lamers CB
Scand J Gastroenterol Suppl; 1996; 218():10-5. PubMed ID: 8865445
[TBL] [Abstract][Full Text] [Related]
17. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
Gallo S; Dibildox M; Moguel A; Di Silvio M; Rodríguez F; Almaguer I; García C
Rev Gastroenterol Mex; 1998; 63(1):11-6. PubMed ID: 10068743
[TBL] [Abstract][Full Text] [Related]
18. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
Festen HP; Schenk E; Tan G; Snel P; Nelis F
Am J Gastroenterol; 1999 Apr; 94(4):931-6. PubMed ID: 10201459
[TBL] [Abstract][Full Text] [Related]
19. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
[TBL] [Abstract][Full Text] [Related]
20. pH, healing rate, and symptom relief in patients with GERD.
Huang JQ; Hunt RH
Yale J Biol Med; 1999; 72(2-3):181-94. PubMed ID: 10780580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
